Confo Therapeutics is a startup based in Belgium, most recent round Series B, 3 tracked investors.
Confo Therapeutics is a startup founded in 2016 based in Belgium. Its most recent tracked round is Series B. Brouky records 3 investors associated with the company.
Confo Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel therapies targeting G-protein coupled receptors (GPCRs) for metabolic and endocrine diseases. The company utilizes its proprietary ConfoBody® technology to stabilize GPCRs in active conformations, enabling the discovery and development of small molecule and antibody-based therapeutics.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.